← Leaderboards
Lih Kuo
Texas A&M University Health Science Ctr
$3,446,874
Attributed
$4,175,968
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $378.8K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,175,968 · 5
By mechanism
R01$3,988,872 · 4
K02$187,096 · 1
Top collaborators
- Travis W Hein4 shared
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Gerald A. Meininger$6,853,442
- David Carl Zawieja$7,448,755
- Jiang Chang$12,014,555
- Mariappan Muthuchamy$4,262,415
- Emily Wilson$1,297,866
Others in their field
Top investigators on “Microcirculation”
- Lilach O Lerman · Mayo Clinic Rochester$12,143,264
- Sarah Y. Yuan · University Of South Florida$11,607,765
- Ruikang Wang · Oregon Health & Science University$11,412,696
- Marlene Rabinovitch · Stanford University$11,244,660
- Charles W. Leffler · University Of Tennessee Health Sci Ctr$11,170,356
- Marcos Intaglietta · University Of California San Diego$10,967,422
Research focus
MicrocirculationOxygenSwineVascular EndotheliumAdenosineCoronary VesselsVascular ResistanceMuscle TonePotassium ChannelNitric OxideAnimalsBlindnessBlood DamageBlood FlowAnimal ModelAgedEffective TherapyElectroretinographyDiabeticAdultDiabetic RetinopathyComplications Of Diabetes MellitusConstrictionDiabetic Angiopathies
Grant awards (15)
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$321,938
R01 · FY2025 · EY
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2024 · EY
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2023 · EY
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2022 · EY
Coronary Dysfunction in Hypertrophic Cardiomyopathy$355,202
R01 · FY2006 · HL · contact PI
Coronary Dysfunction in Hypertrophic Cardiomyopathy$363,750
R01 · FY2005 · HL
Coronary Dysfunction in Hypertrophic Cardiomyopathy$363,750
R01 · FY2004 · HL
Coronary Dysfunction in Hypertrophic Cardiomyopathy$363,750
R01 · FY2003 · HL
REGULATION OF CORONARY MICROVASCULAR TONE$230,995
R01 · FY2002 · HL
REGULATION OF CORONARY MICROVASCULAR TONE$224,268
R01 · FY2001 · HL
L-ARGININE METABOLISM AND CORONARY VASCULAR FUNCTION$208,655
R01 · FY2001 · HL
METABOLIC MODULATION OF CORONARY MICROVASCULAR TONE$99,387
K02 · FY2001 · HL
REGULATION OF CORONARY MICROVASCULAR TONE$217,738
R01 · FY2000 · HL
L-ARGININE METABOLISM AND CORONARY VASCULAR FUNCTION$202,576
R01 · FY2000 · HL
METABOLIC MODULATION OF CORONARY MICROVASCULAR TONE$87,709
K02 · FY2000 · HL